Quick Take
Thymosin Alpha-1 is approved in 35+ countries for hepatitis and as cancer adjunct therapy. It's a powerful immune modulator that enhances T-cell function. During COVID, it gained attention for potential immune support.
How It Works
Simple Explanation
Ta1 helps your immune system work better by improving T-cell function — the cells that fight infections and cancer. It's like a conductor helping your immune orchestra play in tune.
🔬 Technical Details (Click to expand)
Thymosin Alpha-1 enhances T-cell differentiation, increases IL-2 production, augments NK cell activity, and modulates cytokine production. It activates toll-like receptors and improves antigen presentation.
Key Research
Hepatitis B
Approved treatment in multiple countries with improved viral clearance
Cancer Adjunct
Improved outcomes when combined with chemotherapy
COVID-19
Studies suggested improved outcomes in severe cases
Benefits
- Enhances T-cell function
- Approved in 35+ countries
- Cancer adjunct therapy
- May help with chronic infections
- Immune system optimization
Side Effects
- Injection site reactions — Occasional
- Flu-like symptoms — RareSign of immune activation
Typical Dosing
Standard Dose
1.6mg daily or every other day
Forms Available
- • Subcutaneous injection
Frequency
Daily or every other day during acute phase, less frequent for maintenance
⚠️ This is general information only. Always consult a healthcare provider before starting any peptide.
Who It's For
- ✓ Those with chronic viral infections
- ✓ Cancer patients (as adjunct)
- ✓ People seeking immune optimization
- ✓ Those with weakened immune systems
Who Should Avoid
- ✗ Autoimmune conditions (may exacerbate)
- ✗ Organ transplant recipients
- ✗ Those on immunosuppressants
Want the Full Protocol Guide?
Get our comprehensive guide with dosing protocols, stacking strategies, and more.